Modification of the HCMV-specific IFN-γ release test (QuantiFERON-CMV) and a novel proposal for its application
Modification of the HCMV-specific IFN-γ release test (QuantiFERON-CMV) and a novel proposal for its application
复制标题
DOI:
10.5387/fms.2017-01
复制
发表时间:
2017-08-01
影响因子:
0.8
通讯作者:
Suzutani, Tatsuo
中科院分区:
文献类型:
--
作者:
Kobayashi, Takahiro;Sato, Jun-Ichi;Suzutani, Tatsuo
Human cytomegalovirus (HCMV) is universally distributed among humans without any adverse effects; however it induces severe diseases in immunocompromised patients such as organ transplant recipients and AIDS patients. To manage these immunocompromised patients, an easy clinical examination for the monitoring of disease risk is required. In this study, we modified the interferon-gamma (IFN-gamma) release test (QuantiFERON (R) CMV) using HCMV immediate early-1 (IE-1) or pp65 whole proteins, or UV inactivated HCMV particles as an antigen. The response of heparinized peripheral blood from healthy volunteers to the pp65 protein showed an obvious dose-dependent sigmoid curve, although no correlation was observed between results of this assay and an ELISPOT assay. The addition of pp65 to the blood samples at a final concentration of 1x10(3) to 1x10(5) pg/ml was found to be optimum. Using this assay, we observed a significant enhancement in cellular immunity in volunteers after the daily ingestion of yogurt for 8 weeks, which suggested a novel application of the assay in addition to monitoring HCMV infection risk. IFN-gamma secretion from peripheral blood cells on HCMV-antigen stimulation differed significantly between individuals ; therefore, the assay could not be normalized. Nevertheless, it was found to be particularly useful for observing fluctuations in cellular immune activity on an individual level.